GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor

Human Pathology

Volumn 43, Issue 11, 2012, Pages 2033-2040

  Miyamoto, Hiroshi ^a   Izumi, Koji ^a   Yao, Jorge L ^a   Li, Yi ^a   Yang, Qi ^a   McMahon, Loralee A ^a   Gonzalez Roibon, Nilda ^b   Hicks, David G ^a   Tacha, David ^c   Netto, George J ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c Biocare Medical   (United States)

Author keywords

Bladder tumor; GATA3; Immunohistochemistry; Prognosis; Sex hormone receptors

Indexed keywords

ANDROGEN RECEPTOR; BCG VACCINE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; TRANSCRIPTION FACTOR GATA 3;

ADULT; AGED; ARTICLE; BLADDER; BLADDER CANCER; BLADDER TUMOR; CANCER INVASION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; CYSTECTOMY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NON MUSCLE INVASIVE BLADDER CANCER; PREDICTIVE VALUE; PREDICTOR VARIABLE; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION; RECURRENCE FREE SURVIVAL; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; TRANSITIONAL CELL CARCINOMA; TUMOR GROWTH; UROTHELIUM;

CYSTECTOMY; DOWN-REGULATION; GATA3 TRANSCRIPTION FACTOR; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; PROGNOSIS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UNITED STATES; URINARY BLADDER NEOPLASMS;

EID: 84867886926     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.02.011     Document Type: Article

References (34)

1. P.J. Goebell, and M.A. Knowles Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium Urol Oncol 28 2010 409 428
2. H. Miyamoto, J.S. Miller, D.A. Fajardo, T.K. Lee, G.J. Netto, and J.I. Epstein Non-invasive papillary urothelial neoplasms: The 2004 WHO/ISUP classification system Pathol Int 60 2010 1 8
3. R. Siegel, E. Ward, O. Brawley, and A. Jemal Cancer statistics, 2011. The impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer J Clin 61 2011 212 236
4. H. Miyamoto, Y. Zheng, and K. Izumi Nuclear hormone receptor signals as new therapeutic targets for urothelial carcinoma Curr Cancer Drug Tar 12 2012 14 22
5. H. Miyamoto, Z. Yang, and Y.T. Chen Promotion of bladder cancer development and progression by androgen receptor signals J Natl Cancer Inst 99 2007 558 568
6. A.M. Johnson, M.J. O'Connell, and H. Miyamoto Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospodin-1 BMC Urol 8 2008 7
7. J.T. Wu, B.M. Han, S.Q. Yu, H.P. Wang, and S.J. Xia Androgen receptor is a potential therapeutic target for bladder cancer Urology 75 2009 820 827
8. M.P. Waalkes, J. Liu, J.M. Ward, D.A. Powell, and B.A. Diwan Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment Cancer Res 66 2006 1337 1345
9. G. Sonpavde, N. Okuno, and H. Weiss Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma Urology 69 2007 1221 1226
10. J. Teng, Z.Y. Wang, D.F. Jarrard, and D.E. Biorling Roles of estrogen receptor α and β in modulating urothelial cell proliferation Endocr Relat Cancer 15 2008 351 364
11. S. Boorjian, S. Ugras, and N.P. Mongan Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer Urology 64 2004 383 388
12. S.S. Shen, C.L. Smith, and J.T. Hsieh Expression of estrogen receptor-α and -β in bladder cancer cell lines and human bladder tumor tissue Cancer 106 2006 2610 2616
13. C. Bolenz, Y. Lotan, and R. Ashfaq Estrogen and progesterone hormone receptor expression in urothelial carcinoma of the bladder Eur Urol 56 2009 1093 1095
14. C. Tuygun, D. Kankaya, and A. Imamoglu Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: a comparative analysis of clinicopathological features and survival outcomes according to receptor expression Urol Oncol 29 2011 43 51
15. C. Mir, S.F. Shariat, and T.H. van der Kwast Loss of androgen receptor expression is not associated with pathological grade, stage, gender or outcome in bladder cancer: a large multi-institutional study BJU Int 108 2011 24 30
16. H. Miyamoto, J.L. Yao, and A. Chaux Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder BJU Int 2012 in press
17. R.K. Patient, and J.D. McGhee The GATA family (vertebrates and invertebrates) Curr Opin Genet Dev 12 2002 416 422
18. T. Hosoya, I. Maillard, and J.D. Engel From the cradle to the grave: activities of GATA-3 throughout T cell development and differentiation Immunol Rev 238 2010 110 125
19. M.L. Asselin-Labat, K.D. Sutherland, and H. Barker Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation Nat Cell Biol 9 2006 201 209
20. D. Grote, A. Souabni, M. Busslinger, and M. Bouchard Pax2/8-regulated Gata3 expression is necessary for morphogenesis and guidance of the nephric duct in the developing kidney Development 133 2006 53 61
21. H. Kouros-Mehr, E.M. Slorach, M.D. Sternlicht, and Z. Werb GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland Cell 127 2006 1041 1055
22. H. Kouros-Mehr, S.K. Bechis, and E.M. Slorach GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model Cancer Cell 13 2008 141 152
23. A.B. Dydensborg, A.A.N. Rose, and B.J. Wilson GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis Oncogene 28 2009 2634 2642
24. R.V. Hoch, D.A. Thompson, R.J. Baker, and R.J. Weigel GATA-3 is expressed in association with estrogen receptor in breast cancer Int J Cancer 84 1999 122 128
25. S.H. Fang, Y. Chen, and R.J. Weigel GATA-3 as a marker of hormone response in breast cancer J Surg Res 157 2009 290 295
26. B.J. Wilson, and V. Giguère Meta-analysis of human cancer microarrays reveals GATA3 is integral to the estrogen receptor alpha pathway Mol Cancer 7 2008 49
27. J.P.T. Higgins, G. Kaygusuz, and L. Wang Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray Am J Surg Pathol 31 2007 673 680
28. L. Schultz, R. Albadine, and J. Hicks Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy Cancer 116 2010 5517 5526
29. Y. Zheng, K. Izumi, J.L. Yao, and H. Miyamoto Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells Endocr Relat Cancer 18 2011 451 464
30. A. Albergaria, J. Paredes, and B. Sousa Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours Breast Cancer Res 11 2009 R40
31. M.R. Raspollini, I. Sardi, and L. Giunti Plasmacytoid urothelial carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of a case series Hum Pathol 42 2010 1149 1158
32. M.R. Raspollini, C.E. Comin, A. Crisci, and M. Chilosi The use of placental S100 (S100P), GATA3 and napsin A in the differential diagnosis of primary adenocarcinoma of the bladder and bladder metastasis from adenocarcinoma of the lung Pathologica 102 2010 33 35
33. G.E. Esheba, T.A. Longacre, K.A. Atkins, and J.P. Higgins Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital transitional cell proliferation Am J Surg Pathol 33 2009 347 353
34. B. Nicolás Diaz-Chico, F. Germán Rodríguez, and A. González Androgens and androgen receptors in breast cancer J Steroid Biochem Mol Biol 105 2007 1 15